Lifyorli
- Product NDC
- 76346-525
- 11-digit product format
- 763460525
- Labeler code
- 76346
- Product ID
- 76346-525_41bf3142-d0f6-4f0c-b6da-5abe8ad3db43
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Relacorilant
- Dosage form
- KIT
- Route
- ORAL
- Labeler
- Corcept Therapeutics Incorporated
- Application
- NDA220641
- Marketing category
- NDA
- Marketing start
- 2026-03-25
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N220641-001 | LIFYORLI (COPACKAGED) | RELACORILANT | 100MG;25MG | CAPSULE / ORAL | RLD, RS | 2026-03-25 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N220641-001 | 10456392 | 2033-05-24 | U-4457 | 2026-04-21 | |
| N220641-001 | 11576907 | 2033-05-24 | U-4457 | Drug substance, Drug product | 2026-04-21 |
| N220641-001 | 11576907 | 2033-05-24 | U-4458 | Drug substance, Drug product | 2026-04-21 |
| N220641-001 | 11576907 | 2033-05-24 | U-4459 | Drug substance, Drug product | 2026-04-21 |
| N220641-001 | 8859774 | 2033-05-24 | Drug substance, Drug product | 2026-04-21 | |
| N220641-001 | 9273047 | 2033-05-24 | U-4457 | 2026-04-21 | |
| N220641-001 | 9273047 | 2033-05-24 | U-4458 | 2026-04-21 | |
| N220641-001 | 9273047 | 2033-05-24 | U-4459 | 2026-04-21 | |
| N220641-001 | 11925626 | 2039-12-18 | Drug product | 2026-04-21 | |
| N220641-001 | 12514849 | 2039-12-18 | Drug product | 2026-04-21 | |
| N220641-001 | 11464764 | 2040-04-14 | Drug product | 2026-04-21 | |
| N220641-001 | 11285145 | 2041-05-26 | U-4457 | 2026-04-21 | |
| N220641-001 | 11285145 | 2041-05-26 | U-4458 | 2026-04-21 | |
| N220641-001 | 11285145 | 2041-05-26 | U-4459 | 2026-04-21 | |
| N220641-001 | 12589094 | 2041-05-26 | U-4457 | 2026-04-21 | |
| N220641-001 | 12589094 | 2041-05-26 | U-4458 | 2026-04-21 | |
| N220641-001 | 12589094 | 2041-05-26 | U-4459 | 2026-04-21 | |
| N220641-001 | 12152028 | 2041-12-22 | U-4457 | Drug product | 2026-04-21 |
| N220641-001 | 12152028 | 2041-12-22 | U-4458 | Drug product | 2026-04-21 |
| N220641-001 | 12152028 | 2041-12-22 | U-4459 | Drug product | 2026-04-21 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N220641-001 | NCE | 2031-03-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | LIFYORLI (COPACKAGED) | 100MG;25MG | CAPSULE / ORAL | RLD, RS | 2026-03-25 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 10456392 | 2033-05-24 | U-4457 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11576907 | 2033-05-24 | U-4458 | Drug substance, Drug product | 2026-04-21 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11576907 | 2033-05-24 | U-4457 | Drug substance, Drug product | 2026-04-21 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11576907 | 2033-05-24 | U-4459 | Drug substance, Drug product | 2026-04-21 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 8859774 | 2033-05-24 | Drug substance, Drug product | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 9273047 | 2033-05-24 | U-4457 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 9273047 | 2033-05-24 | U-4458 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 9273047 | 2033-05-24 | U-4459 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11925626 | 2039-12-18 | Drug product | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12514849 | 2039-12-18 | Drug product | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11464764 | 2040-04-14 | Drug product | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11285145 | 2041-05-26 | U-4458 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11285145 | 2041-05-26 | U-4457 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 11285145 | 2041-05-26 | U-4459 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12589094 | 2041-05-26 | U-4457 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12589094 | 2041-05-26 | U-4458 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12589094 | 2041-05-26 | U-4459 | 2026-04-21 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12152028 | 2041-12-22 | U-4457 | Drug product | 2026-04-21 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12152028 | 2041-12-22 | U-4458 | Drug product | 2026-04-21 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | 12152028 | 2041-12-22 | U-4459 | Drug product | 2026-04-21 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220641-001 | NCE | 2031-03-25 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lifyorli
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2739542 | Internal RxNorm lookup |
| 2739548 | Internal RxNorm lookup |
| 2739550 | Internal RxNorm lookup |
| 2739552 | Internal RxNorm lookup |
| 2739553 | Internal RxNorm lookup |
| 2739554 | Internal RxNorm lookup |
| 2739555 | Internal RxNorm lookup |
| 2739556 | Internal RxNorm lookup |
| 2739557 | Internal RxNorm lookup |
| 2739558 | Internal RxNorm lookup |
| 2739559 | Internal RxNorm lookup |
| 2739560 | Internal RxNorm lookup |
| 2739561 | Internal RxNorm lookup |
| 2739562 | Internal RxNorm lookup |
| 2739563 | Internal RxNorm lookup |
| 2739564 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6fcebfb5-19d6-4f63-b852-999d68a13729 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76346-025-01 | Lifyorli | 1 in 1 PACKAGE, COMBINATION | CAPSULE | 3 | 25 mg | 1 |
| 76346-100-01 | Lifyorli | 1 in 1 PACKAGE, COMBINATION | CAPSULE | 3 | 100 mg | 1 |
| 76346-525-03 | Lifyorli | 1 in 1 CARTON | KIT | 1 | 1 | |
| 76346-525-09 | Lifyorli | 3 in 1 CARTON | KIT | 3 | 1 | |
| 76346-525-33 | Lifyorli | 1 in 1 BLISTER PACK | KIT | 1 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76346-525-03 | EA - Each | 76346-525 | fa8b5c68-3f17-4d63-b852-5af750424585 | 1 | 2026-04-20 |
| 76346-525-09 | EA - Each | 76346-525 | 2448f279-33d9-4685-85d6-936463d70ec4 | 1 | 2026-04-20 |
| 76346-525-33 | EA - Each | 76346-525 | 99b30a9b-99c3-48e3-829c-720e7baac6ee | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lifyorli | RELACORILANT | Corcept Therapeutics Incorporated | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 2026-03-26 | Warnings, Adverse reactions | 220641 NDA220641 76346-525 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2739554 | {1 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 1 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 125 MG, 1-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739556 | {1 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 2 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 1-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739558 | {3 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 3 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 125 MG, 3-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739562 | {3 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 6 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 3-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739564 | {9 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 18 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 9-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739560 | {9 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 9 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 125 MG, 9-Dose Supply] | BPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739553 | {1 (relacorilant 100 MG Oral Capsule) / 1 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739555 | {1 (relacorilant 100 MG Oral Capsule) / 2 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739557 | {3 (relacorilant 100 MG Oral Capsule) / 3 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739561 | {3 (relacorilant 100 MG Oral Capsule) / 6 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739563 | {9 (relacorilant 100 MG Oral Capsule) / 18 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739559 | {9 (relacorilant 100 MG Oral Capsule) / 9 (relacorilant 25 MG Oral Capsule) } Pack | GPCK | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739548 | Lifyorli 100 MG Oral Capsule | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739554 | Lifyorli 125 MG, 1-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739558 | Lifyorli 125 MG, 3-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739560 | Lifyorli 125 MG, 9-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739556 | Lifyorli 150 MG, 1-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739562 | Lifyorli 150 MG, 3-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739564 | Lifyorli 150 MG, 9-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739552 | Lifyorli 25 MG Oral Capsule | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739542 | relacorilant 100 MG Oral Capsule | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739553 | relacorilant 125 MG, 1-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739557 | relacorilant 125 MG, 3-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739559 | relacorilant 125 MG, 9-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739555 | relacorilant 150 MG, 1-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739561 | relacorilant 150 MG, 3-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739563 | relacorilant 150 MG, 9-Dose Pack | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739550 | relacorilant 25 MG Oral Capsule | PSN | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739548 | relacorilant 100 MG Oral Capsule [Lifyorli] | SBD | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739552 | relacorilant 25 MG Oral Capsule [Lifyorli] | SBD | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739542 | relacorilant 100 MG Oral Capsule | SCD | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739550 | relacorilant 25 MG Oral Capsule | SCD | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739548 | Lifyorli 100 MG Oral Capsule | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739554 | Lifyorli 125 MG, 1-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739558 | Lifyorli 125 MG, 3-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739560 | Lifyorli 125 MG, 9-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739556 | Lifyorli 150 MG, 1-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739562 | Lifyorli 150 MG, 3-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739564 | Lifyorli 150 MG, 9-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739552 | Lifyorli 25 MG Oral Capsule | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739553 | relacorilant 125 MG, 1-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739557 | relacorilant 125 MG, 3-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739559 | relacorilant 125 MG, 9-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739555 | relacorilant 150 MG, 1-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739561 | relacorilant 150 MG, 3-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
| 2739563 | relacorilant 150 MG, 9-Dose Pack | SY | 6fcebfb5-19d6-4f63-b852-999d68a13729 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76346-025-01 | 76346002501 | 1 in 1 PACKAGE, COMBINATION | Historical | ||||
| 76346-100-01 | 76346010001 | 1 in 1 PACKAGE, COMBINATION | Historical | ||||
| 76346-525-03 | 76346052503 | 1 BLISTER PACK in 1 CARTON (76346-525-03) / 1 KIT in 1 BLISTER PACK (76346-525-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01) | 1 blister pack | 2026-03-25 | No | No | Current |
| 76346-525-09 | 76346052509 | 3 CARTON in 1 CARTON (76346-525-09) / 1 BLISTER PACK in 1 CARTON (76346-525-03) / 1 KIT in 1 BLISTER PACK (76346-525-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01) | 3 carton | 2026-03-25 | No | No | Current |
| 76346-525-33 | 76346052533 | 1 in 1 BLISTER PACK | Historical |